Skip to main content

Month: February 2021

PST pasirašė 21,083 mln. Eur vertės sutartį dėl Lazdynų baseino statybų Vilniuje

AB Panevėžio statybos trestas (PST) po laimėto viešojo konkurso pasirašė sutartį su Vilniaus miesto savivaldybe dėl Lazdynų baseino statybos darbų. Bendra sutarties vertė siekia 21,083 mln. eurų (su PVM). Baseino statybos darbus planuojama atnaujinti artimiausiu metu, o juos baigti numatoma iki 2022 m. pradžios.Lazdynų daugiafunkciniame sveikatinimo centre bus įrengti du modernūs 50 ir 25 metrų ilgio plaukimo baseinai, šalia kurių suprojektuotos 1200 sėdimų vietų žiūrovams. Centre taip pat veiks treniruočių salės, pirčių zonos, bus įrengti modernūs dušai ir persirengimo kambariai lankytojams. Šalia pastato įsikurs 105 vietų automobilių stovėjimo aikštelė, bus atnaujinta aplinkinė infrastruktūra ir viešosios erdvės.Lazdynų baseino rekonstrukcija pradėta 2017 m., tačiau 2019-aisiais buvo sustabdyta, veiklą nutraukus ankstesniam rangovui....

Continue reading

Annual Report of Jyske Realkredit A/S for the financial year 2020

To NASDAQ Copenhagen A/S                                                                                                                23 February 2021                                                                                                                Announcement no. 21/2021Annual Report of Jyske Realkredit A/S for the financial year 2020On February 23, 2021, the Board of Directors has approved the Annual Report of Jyske Realkredit A/S for the financial year 2020.Please see attached files.Yours sincerely,Jyske Realkredit A/SCarsten Tirsbæk MadsenCEODirect phone (+45) 89 89 90 50E-mail ctm@jyskerealkredit.dkWeb: jyskerealkredit.dkPlease observe that the Danish version of this announcement prevails.Attached files:Jyske Realkredit Preliminary announcement of financial statements 2020.pdfJyske Realkredit Annual Report 2020.pdfAttachmentsJyske...

Continue reading

Årsrapport for Jyske Realkredit A/S 2020

Til NASDAQ Copenhagen A/S                                                                                                                                                                                                                          23. februar 2021                                                                                                               Meddelelse nr. 21/2021Årsrapport for Jyske Realkredit A/S 2020Bestyrelsen har den 23. februar 2021 godkendt Jyske Realkredits årsrapport for 2020.Se venligst vedlagte filer.Venlig hilsenJyske Realkredit A/SCarsten Tirsbæk MadsenAdm. direktørDirekte: 89 89 90 50E-mail: ctm@jyskerealkredit.dkWeb: jyskerealkredit.dkVedlagte filer:Jyske Realkredit Regnskabsmeddelelse 2020.pdfJyske Realkredit Årsrapport 2020.pdfVedhæftede filerJyske Realkredit Regnskabsmeddelelse 2020Jyske Realkredit...

Continue reading

G4S plc – Outcome of Auction Process

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.FOR IMMEDIATE RELEASE23 February 2021G4S plc (“G4S” or the “Company”)Outcome of Auction ProcessThe Board of G4S notes the recent announcements by Garda World Security Corporation (“GardaWorld”) declaring that its cash offer of 235 pence per G4S share is final and will not be revised (the “Final GardaWorld Offer”) and that Allied Universal Topco LLC (“Allied Universal”) has confirmed to the Takeover Panel that it will not revise its cash offer of 245 pence per G4S share (the “Final Allied Universal Offer”).  The Allied Universal announcement (the “Allied Announcement”) containing details regarding the Final Allied Universal Offer and further regulatory...

Continue reading

OKYO Pharma has U.S. Patent Issued Covering its Lipid Conjugated Peptide Analogues for treating Ocular Pain and Inflammation

LONDON, Feb. 23, 2021 (GLOBE NEWSWIRE) — OKYO Pharma Limited (“OKYO” or the “Company”), a biotechnology company focused on the development of novel drugs to treat inflammatory eye diseases and chronic ocular pain, today announced that patent No. 10,899,796 entitled “Compounds and Methods for Treating Pain” was issued by the United States Patent and Trademark Office (“USPTO”) on January 26, 2021. This patent covers a class of bovine adrenal medulla (BAM) peptides linked to specific lipids that demonstrate potential for treating symptoms of neuropathic pain, ocular pain, ocular inflammation and/or dry eye disease.The work recited in this patent lays out the potential of this class of lipidated BAM analogues as non-opioid analgesics for ocular pain management without the side effects and potential abuse associated...

Continue reading

Caledonia Mining Corporation Plc: Appointment of Independent Non-Executive Director

ST HELIER, Jersey, Feb. 23, 2021 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (NYSE AMERICAN: CMCL; AIM: CMCL) (“Caledonia” or the “Company”) announces that Mrs Geralda Wildschutt has joined the Board of Directors of the Company as an independent Non-Executive Director with immediate effect.Mrs Wildschutt brings a wealth of experience with 25 years working in social development and stakeholder management in the fields of social performance, community relations in mining operations, financial services and industry bodies focused on responsible mining.Over the last five years she has been a consultant to Anglo American, Gold Fields, Ivanhoe Mines and South32 on a range of social performance areas, including social investment, ESG compliance, human rights and social impact assessments, strengthening of community trusts, capacity...

Continue reading

RenalytixAI to announce Financial Results for six and three months ended December 31, 2020

NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) — Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) (“RenalytixAI” or the “Company”), the artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces that it will report its financial results for the six and three months ended December 31, 2020 on Tuesday, March 2, 2021.Analyst conference callThe Company will hold an analyst conference call at 8:30 a.m. (EST) / 1:30 p.m. (GMT) p.m. on Tuesday, March 2, 2021. James McCullough, CEO and O. James Sterling, CFO will discuss the financial results and provide a corporate update.Conference Call DetailsUS/CANADA Participant Toll-Free Dial-In Number: (833) 614-1551US/CANADA Participant International Dial-In Number: (914)...

Continue reading

Radview Software completes financing round, Accelerates Development of New Product Line and Expands Marketing Activities

Rosh Ha’ain, Israel, Feb. 23, 2021 (GLOBE NEWSWIRE) — Radview Software Ltd. (“Radview” or the “Company”;  OTC Pink: RDVWF), a leading provider of enterprise-grade performance and load testing solutions, announced today that it had closed a financing round from a consortium of investors.The funds will be used to boost the Company’s marketing and business development activities, expand its product line, and solidify its technological leadership.Avraam Fried, who led the financing round and joined the Company’s Board of Directors, noted: “We have identified in Radview a unique combination of superior proven technology and rare domain expertise. We believe that the financing shall allow Radview to expand its business and capitalize on the currently favorable market conditions.”Eyal Shalom, Radview’s CEO, added: “We are delighted...

Continue reading

4. kvartal 2020: Jobindex er på vej tilbage for fuld fart

Jobmarkedet har overhalet niveauet før Corona-krisenAntallet af nyindrykkede jobannoncer er på 102% af niveauet for et år sidenJobindex fik hidtil højeste omsætning i 4. kvartal og slutter året med et flot resultat og tro på 2021Bedste kvartal hidtil nogensinde“Vi omsatte for 86 mio. kr. i 4. kvartal 2020 mod 76 mio. kr. i samme periode året før,” fortæller Kaare Danielsen. “Det er den højeste omsætning nogensinde. Driftsoverskuddet før renter og skat blev på 26 mio. kr. mod 18 mio. kr. året før – det er meget tilfredsstillende.”2020 slutter godt på trods af CoronaFor 2020 som helhed var Jobindex-koncernens nettoomsætning på 280 mio. kr. mod 314 mio. kr. i 2019, et fald på 11%. Driftsresultat før renter og skat blev på 75 mio. kr., et fald på 16% i forhold til 2019-resultatet på 89 mio. kr. “Dermed...

Continue reading

Europe Dietary Supplements Market Worth $33.80 Billion by 2027; Prominent Companies Such as Archer Daniels and Nestle to Focus on Widening Their Business Horizons: Fortune Business Insights™

Pune, India, Feb. 23, 2021 (GLOBE NEWSWIRE) — The Europe dietary supplements market size is projected to reach $33.80 Billion by 2027, exhibiting a CAGR of 9.3% during the forecast period. The rapid spread of the coronavirus across Europe has brought to the fore the importance of dietary supplements in the recent months, states Fortune Business Insights™ in its report, titled “Europe Dietary Supplements Market Size, Share & COVID-19 Impact Analysis, By Type (Vitamins, Minerals, Enzymes, Fatty Acids, Proteins, and Others), Form (Tablets, Capsules, Powder, and Liquid), and Regional Forecasts, 2020 – 2027”. Dietary supplements consisting of specific vitamins, proteins, and other micronutrients have been proven to be effective in strengthening the immune system’s response to the COVID infection. A study conducted by researchers...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.